Rezulin®
Manufacturer:
Warner-Lambert
Uses: Prescribed to diabetics who took insulin but whose blood sugar was not well controlled.
More Information
 |
| Rezulin |
On March 21, 2000 head of the FDA's center for Drug evaluation and Research
stated that the "Continued use of Rezulin" posed an "unacceptable risk" to
diabetes patients. At least 63 Rezulin users have died of liver failure. The
total number of deaths is estimated to be as many as ten times higher than the
reported 63 cases.
Rezulin was approved for diabetics who used insulin and took certain types of
oral antihyperglycemic medications or fodiabetics. The patient's diabetes could
not be controlled by diet and exercise alone.
Rezulin was banned in England in December 1997, following the death of an
American who took the drug. The drug manufacturer, Warner-Lambert successfully
fought a ban in the U.S. for 27 months before the FDA decided to prohibit sales
of the drug on March 21, 2000.
Before the ban, sales of Rezulin generated Warner-Lambert $1.8 billion in
revenues. At its peak, the drug was prescribed 488,000 times in January of 1999.
For more information:
Pharmaceutical Litigation
Prescription
Injury FAQs
Pharmaceutical Legal Glossary
|
